Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiqudosin Injection for Cancer-Related Severe Pain
CTR20132460Phase 2Suspended
- Sponsor
- Nanning Maple Leaf Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tiqudosin in cancer pain, sponsored by Nanning Maple Leaf Pharmaceutical. Started May 2014; status: suspended.
02
Drugs
tiqudosin
03
Conditions
cancer pain
Beyond the preview
Go deeper on CTR20132460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20132460.